gene_symbol
EGFR
hgnc_id
HGNC:3236
binding_type
other
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Osimertinib irreversibly inhibits mutant EGFR (L858R) kinase activity, blocking downstream MAPK/PI3K signaling and inducing apoptosis of EGFR-mutant tumor cells.
enzyme_product
Off
epitope
Off
variant
On
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Irreversible covalent binding at kinase Cys797
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05816252
disease_id_num_tar_ref
3934
drug_id_num_tar_ref
10631